Foxp3DEx2 isoform expression leads to Treg dysfunction and SLE
Foxp3DEx2 isoform expression leads to Treg dysfunction and SLE
批准号:
10363690
负责人:
Steven F Ziegler
金额:
$21.76万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-03-03 至 2023-08-31
关键词:
AgeAlternative SplicingAmino Acid SequenceAnimal ModelAntibodiesAsthmaAutoantibodiesAutoimmuneAutoimmune DiseasesAutoimmunityCellsColitisComplementComplexDNADataDepositionDevelopmentDiseaseExonsFOXP3 geneFrequenciesFunctional disorderGene StructureHomeostasisHumanHypersensitivityImmuneImmune responseImmune systemImpairmentInflammationKidneyLengthLinkLongevityMediatingMindModelingMouse StrainsMusMutationPathologyPatientsPlayPredispositionProtein IsoformsRNA SplicingRegulatory T-LymphocyteResearch DesignRodentRoleSelf ToleranceStructure of germinal center of lymph nodeSyndromeSystemic Lupus ErythematosusT-Cell ActivationT-Lymphocyte SubsetsTestingeffector T cellhuman femalehuman subjectin vivomaleperipheral tolerancesingle cell analysistranscription factor
中文摘要
项目摘要
调节性T(Treg)细胞在维持免疫系统动态平衡和
调节免疫反应。Foxp3是Treg发育和功能的主要调节因子。Foxp3
IPEX患者的突变导致Tregs缺陷,导致致命性自身免疫,类似于
在Foxp3缺陷小鼠身上观察到的这种疾病。在氨基酸序列和基因上都高度保守
结构上,人和小鼠的一个不同之处是,人的FOXP3基因编码两个主要的
选择性剪接异构体:使用全部10个外显子的全长版本(FOXP3-FL,小鼠唯一的异构体)
而缺乏序列的较短的异构体在调节Th17分化中起重要作用。近期
研究表明,某些自身免疫性疾病患者的Tregs表达水平升高
∆E2亚型与健康献血者的比较。与这一发现一致的是,我们发现特雷格斯
来自系统性红斑狼疮患者的FOXP3∆EX2亚型表达增加。
为了研究∆E2亚型在Treg功能中的作用,我们用Foxp3产生了一个新的小鼠品系
外显子2缺失。有趣的是,我们发现FOXP3∆E2小鼠出现了系统性红斑狼疮的特征,包括抗-
DNA和抗核自身抗体,自发性生发中心和肾脏的数量和大小增加
4-5周龄时抗体复合体沉积。然而,这些小鼠并没有发育成熟。
并拥有正常的寿命。我们的中心假设是由外显子2编码的区域
Foxp3基因对Treg的正常识别和功能至关重要。为了检验这一假设,我们将采用2
接近了。首先,我们将测定在健康人中FOXP3-FL和-∆EX2的表达水平
受试者和自身免疫性疾病的受试者。这些研究将与用小鼠进行的研究相辅相成
含有不同比例的表达每种异构体的Tregs。其次,我们检验了Tregs的假设
表达FOXP3-∆EX2降低了调节效应T细胞激活的能力
克隆和小鼠转移结肠炎模型。总之,这些研究将使我们能够获得重要的信息
FOXP3∆EX2的表达及表达该异构体的Tregs的功能
英文摘要
Project Summary
Regulatory T (Treg) cells play a central role in maintaining immune system homeostasis and
modulating immune responses. Foxp3 is a master regulator of Treg development and function. FOXP3
mutations in patients with IPEX, which result in a deficiency in Tregs, result in lethal autoimmunity, similar to
the disease observed in Foxp3 deficient mice. While highly conserved in both amino acid sequence and gene
structure, one difference between humans and mice is that the human FOXP3 gene encodes two major
alternatively spliced isoforms: a full length version that uses all 10 exons (FOXP3-FL, the only isoform in mice)
and a shorter isoform lacking sequences shown to be important in regulating Th17 differentiation. Recent
studies have shown that Tregs from patients with some autoimmune diseases express increased levels of the
∆E2 isoform compared to those from healthy donors. Consistent with this finding, we have found that Tregs
from SLE patients have increased expression of the FOXP3∆Ex2 isoform.
To study the role of the ∆E2 isoform in Treg function we generated a new mouse strain with Foxp3
exon 2 deletion. Interestingly, we found that Foxp3∆E2 mice develop hallmark features of SLE, including anti-
DNA and anti-nuclear autoantibodies, increased number and size of spontaneous germinal centers and kidney
deposition of antibody complexes, by 4-5 weeks of age. However, these mice do not develop full-blown
disease and have a normal life span. Our central hypothesis is that the region encoded by exon 2 of
Foxp3 gene is critical for normal Treg identity and function. To test this hypothesis we will take 2
approaches. First, we will determine the levels of FOXP3-FL and -∆Ex2-expressing Tregs in healthy human
subjects and subjects with autoimmune disease. These studies will be complemented with studies using mice
containing varying ratios of Tregs expressing each isoform. Second, we test the hypothesis that Tregs
expressing FOXP3-∆Ex2 have a reduced ability to regulate effector T cell activation, using both human Treg
clones and a mouse transfer colitis model. Together these studies will allow us to gain important information
on the expression of FOXP3∆Ex2 and the function of Tregs expressing this isoform.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4049/jimmunol.2200610
发表时间:
2023-04-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Chiu H, Linsley PS, Ziegler SF]
通讯作者:
Ziegler SF
Foxp3 isoforms and IgE-mediated UVB-induced skin inflammation expression
-
批准号:10728256
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2023
-
负责人:Steven F Ziegler
-
依托单位:
Regulation of Tfh function in autoimmunity by TSLP
-
批准号:10441850
-
项目类别:
-
资助金额:$25.95万
-
财政年份:2022
-
负责人:Steven F Ziegler
-
依托单位:
Regulation of Tfh function in autoimmunity by TSLP
-
批准号:10571867
-
项目类别:
-
资助金额:$21.66万
-
财政年份:2022
-
负责人:Steven F Ziegler
-
依托单位:
Epithelial regulation of ECM and leukocyte adhesion in viral-triggered asthma
-
批准号:10160630
-
项目类别:
-
资助金额:$8.58万
-
财政年份:2020
-
负责人:Steven F Ziegler
-
依托单位:
Epithelial control of responses to allergen challenge and viral exacerbation
-
批准号:10168800
-
项目类别:
-
资助金额:$92.44万
-
财政年份:2020
-
负责人:Steven F Ziegler
-
依托单位:
Epithelial regulation of ECM and leukocyte adhesion in viral-triggered asthma
-
批准号:10202414
-
项目类别:
-
资助金额:$43.24万
-
财政年份:2020
-
负责人:Steven F Ziegler
-
依托单位:
Generating tolerance to antibody-based drugs
-
批准号:9258339
-
项目类别:
-
资助金额:$25.5万
-
财政年份:2017
-
负责人:Steven F Ziegler
-
依托单位:
Epithelial control of responses to allergen challenge and viral exacerbation
-
批准号:9157669
-
项目类别:
-
资助金额:$167.83万
-
财政年份:2016
-
负责人:Steven F Ziegler
-
依托单位:
Epithelial control of responses to allergen challenge and viral exacerbation
-
批准号:9315099
-
项目类别:
-
资助金额:$159.11万
-
财政年份:2016
-
负责人:Steven F Ziegler
-
依托单位:
IL-33 and food allergy
-
批准号:9509328
-
项目类别:
-
资助金额:$56.63万
-
财政年份:2016
-
负责人:Steven F Ziegler
-
依托单位:
IL-33 and food allergy
-
批准号:9304962
-
项目类别:
-
资助金额:$70.95万
-
财政年份:2016
-
负责人:Steven F Ziegler
-
依托单位:
A FOXP3 complex that controls human regulatory T cell function
-
批准号:8821198
-
项目类别:
-
资助金额:$27.19万
-
财政年份:2015
-
负责人:Steven F Ziegler
-
依托单位:
A FOXP3 complex that controls human regulatory T cell function
-
批准号:9052703
-
项目类别:
-
资助金额:$42.45万
-
财政年份:2015
-
负责人:Steven F Ziegler
-
依托单位:
Control of tumor growth and metastasis by the cytokine TSLP
-
批准号:9042828
-
项目类别:
-
资助金额:$9.47万
-
财政年份:2015
-
负责人:Steven F Ziegler
-
依托单位:
c-Ski and the regulation of CD4 T cell-mediated autoimmunity and tolerance
-
批准号:9306753
-
项目类别:
-
资助金额:$42.75万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
A FOXP3 complex that controls human regulatory T cell function
-
批准号:8896220
-
项目类别:
-
资助金额:$43.7万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
Control of tumor growth and metastasis by the cytokine TSLP
-
批准号:9207142
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
c-Ski and the regulation of CD4 T cell-mediated autoimmunity and tolerance
-
批准号:8603149
-
项目类别:
-
资助金额:$42.75万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
Control of tumor growth and metastasis by the cytokine TSLP
-
批准号:8728493
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
Control of tumor growth and metastasis by the cytokine TSLP
-
批准号:8827304
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2014
-
负责人:Steven F Ziegler
-
依托单位:
海外基金